Difference between revisions of "Buonamici S, et al. Sci. Transl. Med. (2010) cited as Ref 230 in DOI: 10.1038/s41392-020-0110-5 (Q9493)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 20881279, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 51ra70-, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2010
Timestamp+2010-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2010 / rank
 +
Normal rank
Property / Published In Name String
 +
Sci. Transl. Med.
Property / Published In Name String: Sci. Transl. Med. / rank
 +
Normal rank
Property / Volume
 +
2
Property / Volume: 2 / rank
 +
Normal rank
Property / title
 +
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English)
Property / title: Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English) / rank
 +
Normal rank
Property / Page(s)
 +
51ra70-
Property / Page(s): 51ra70- / rank
 +
Normal rank

Latest revision as of 15:34, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Buonamici S, et al. Sci. Transl. Med. (2010) cited as Ref 230 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Buonamici S
    0 references
    0 references
    2010
    0 references
    Sci. Transl. Med.
    0 references
    2
    0 references
    Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English)
    0 references
    51ra70-
    0 references